Connection
James Burton to Liver Cirrhosis
This is a "connection" page, showing publications James Burton has written about Liver Cirrhosis.
|
|
Connection Strength |
|
 |
|
 |
|
0.254 |
|
|
|
-
Verna EC, Saxena V, Burton JR, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS, Terrault NA. Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study. Transplantation. 2015 Aug; 99(8):1644-51.
Score: 0.111
-
Berman K, Tandra S, Forssell K, Vuppalanchi R, Vuppalanch R, Burton JR, Nguyen J, Mullis D, Kwo P, Chalasani N. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol. 2011 Mar; 9(3):254-9.
Score: 0.080
-
Burton JR, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. J Clin Gastroenterol. 2007 Jul; 41(6):609-15.
Score: 0.063
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|